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Abstract
The lactating mammary gland contains a stem cells population with 
multilineage potentialities. Recently it was also shown that breast milk 
contains a heterogeneous population of stem cells that have the potential to 
differentiate in vitro, under the control of specific differentiation conditions, 
into mammary epithelial as well as into adipogenic, chondrogenic and 
osteogenic cell lineages. While the different types of cells present in the milk 
is known, what is less understood is the proportion of different milk cell types, 
their significance for the mother and the infant and factors influencing them.
In this manuscript we summarize some of the latest knowledge from in vivo 
and in vitro investigations on breast milk stem cells, we discuss their potential 
functions and applications and we present some of our preliminary data 
obtained in fresh human breast milk cells. 
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Introduction
Recent researches concerning the isolation and 
characterization of stem cells, the discovery of 
signaling pathways involved in their self-renewal 
and survival, and their potential role in diseases 
(such as cancer) highlight the potential of these cells 
and we now start to discuss a potential use of adult 
stem cell plasticity in bioengineering and tissue 
regeneration as well as new strategies of cancer 
therapies [1].
Stem cells are distinguished from other cell 
types because they have the ability to self-renew 
and to develop into more differentiated cells. 
Therefore, when a stem cell divides, each new cell 
has the potential either to remain a stem cell or to 
become another type of cell with a more specialized 
function, such as a muscle cell, a red blood cell, or 
a brain cell. 
One of the most important element able 
to govern the stem cells capacity is the local 
environment, called the stem cells niche. Biological 
signal generated in the niche by cell adhesion or 
by interaction between different types of cells is 
thought to be one the control mechanism of stem 
cells activity [2, 3]. 
We may distinguish two kinds of stem cells: 
the most primitive embryonic stem cells and the 
adult stem cell. The embryonic stem cells have 
an extraordinary differentiation potential and can 
mature into a fully developed organism. The adult 
stem cells are generally quiescent cells that may 
generate new stem cells or more committed progeny 
or both [4, 5]. 
Stem cells buffered within specialized niches 
in adult tissues maintain homeostasis during tissue 
turnover or injury and represent a sort of internal 
repair system [6]. 
For example, the mammary gland is metabolical- 
ly active, having the capacity to undergo cycles 
of extensive proliferation and hypertrophy (during 
pregnancy and lactation) and involution. The 
presence of mammary stem cells are necessary in 
order to give rise to different components of the 
lactation process. These cells proliferate extensive- 
ly and differentiate during each pregnancy and 
lactation and undergo apoptosis during mammary 
involution [7, 8].
In order to identify and to study the functional 
properties of stem cells, several in vitro systems 
have been proposed. The task has been proved to be 
technically difficult because of the scarcity of stem 
cells in the tissue of origin, and the lack of universal 
morphologic traits for stem cells [9].
Recently it has been reported that breast milk 
contains a heterogeneous cell population; among 
this, a subpopulation with stem cell properties 
(including the ability to differentiate into 
different cell lineages) has been isolated from 
human fresh milk [10, 11]. Stem cells detected 
in mammary gland tissue with the differentiation 
capacity to originate mammary epithelial cell and 
myoepithelial cells [12] have been considered as 
the sources of stem cells in breast milk [13]. The 
presence of exfoliated epithelial cells from alveoli, 
macrophages, and lymphocytes was also reported 
[14, 15]. It was also observed that 10-15% of the 
cells isolated from fresh breast milk expressed 
mesenchymal stem cell (MSC) markers; culturing 
these isolated cells led to an increase in the MSC 
population, due to their higher capacity of cell 
proliferation [10].
Breast milk has long been known to contain 
maternal cells [16], but only recently it has been 
possible to distinguish, among these cells, immune 
cells and milk stem cells. For decades, milk was 
considered only from a nutritional point of view and 
just recently we have started to study a possible role 
of protective cells in breast milk. As the mammary 
gland is characterized by a significant remodeling 
during pregnancy, also the milk composition 
changes, not only in the nutritional elements, but 
also in the presence of different patterns of cells 
during lactation [17, 18].
While the different types of cells present in 
the milk is known, their significance and factors 
influencing them are less well understood. Only 
few data are available regarding the human stem 
cell composition in the fresh maternal human milk, 
but some information regarding the functions and 
characteristics of these cells comes from in vitro 
and animals experimental studies.
Recently, using female genetically modified 
mice whose cells contain a gene called tdTomato, 
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which makes them red under fluorescent light, it 
has been found that in unmodified lactating mice 
breastfed by tdTomato, female red stem cells cross 
into the offspring’s blood through their stomach 
and play a functional role later in life. When the 
offspring reached adulthood, red cells were found 
in their blood and in many of their tissues, including 
brain, thymus, pancreas, liver, spleen and kidneys. 
These data suggest a possible migration and a 
functional integration into organs of maternal milk 
stem cells in the neonate [19]. 
Breast milk comprises epithelial cells, colostral 
corpuscles, polymorphonuclear leukocytes, mono- 
nuclear phagocytes, lactocytes and lymphocytes 
forming the main bulk of cells within two weeks of 
lactation [14, 20-22]. 
It was hypothesized that these epithelial cells are 
shed from the ductal and luminal epithelial layers 
through either a heightened turnover of the secretory 
tissue, or as a consequence of the mechanical 
shear forces associated with the continued filling 
and emptying cycle associated with breast milk 
synthesis and lactation [23].
Markers of breast milk stem cells
These putative mammary stem cells present 
in the milk were first identified through their 
expression of various cytokeratin (CK) markers 
(like CK5, CK14 and CK19) and nestin [24] but, 
even if in some cases there are contrasting data, 
other hallmarks of milk stem/progenitor cells have 
already been established [23].
By isolating and expanding MSC-like cells popu- 
lation from human breast milk, it is now possible 
to study their pluripotency using various culture 
conditions [25]. These cultured cells, examined 
by immunofluorescent labeling, were positive for 
MSC surface markers (like CD44, CD29, Sca-1) and 
negative for CD33, CD34, CD45, CD73, confirming 
their identity as MSCs. Cytoskeletal protein 
marker analysis revealed that these cells expressed 
MSCs markers, namely nestin, vimentin, smooth 
muscle actin. Moreover, it also manifested presence 
of E-cadherin, an epithelial-to-mesenchymal tran- 
sition marker in their early passages. Also the 
multipotent differentiation potential of stem cells 
was proved; they can differentiate into adipogenic, 
chondrogenic and osteogenic lineage under the control 
of specific in vitro differentiation systems. This 
means that these MSCs, isolated from human breast 
milk, could potentially be “reprogrammed” to form 
many types of human tissues [26].
Human breast milk stem cells: a new challenge for perinatologists
Breast milk as a new source of endogenous 
stem cells
The presence of multipotent stem cells in human 
milk suggests that breast milk could be an alternative 
source of stem cells for autologous stem cell therapy, 
although the actual significance of these cells needs 
to be more delineated.
It was also shown the presence of a cellular 
hierarchy in breast milk, from multipotent stem 
cells to progenitors to more differentiated mammary 
cells [11, 17].
The cell concentration in milk may range widely 
from 1 x 103 to 8 x 105 cells per mL, which seems to 
be not related to the duration of lactation [14, 23]. 
In another study, the total number of cells obtained 
from 1 mL of breast milk ranged between 2.5 and 3 
million cells [26, 27].
Freshly isolated human breast milk cells contained 
10-15% of CD44, CD29 and Sca-1 positive cells, 
and, when isolated and cultured in vitro, these cells 
significantly increased up to 90% after 4 in culture 
confluence passages. The immunofluorescence study 
for specific cell surface markers clearly indicated 
that these cells express mesenchymal markers (like 
SMA, vimentin, nestin) and surface markers (like 
CD44, CD29, Sca-1). These cells were found to be 
negative for CD33, CD34, CD45, CD73, confirming 
their identity as MSCs [27].
Large inter- and intra-individual variations 
exist in cell breast milk composition and it seems that 
they are correlated with breastfeeding stimulation, 
week of gestation and stage of lactation, but these 
variations are still not well understood. Probably 
this phenomenon is responsible for the variability 
of the published data; it is time now to establish a 
standardization of sampling protocols in lactation 
studies and investigation of the mechanisms of milk 
synthesis and cell movement into breast milk [28]. 
The majority of the published data regarding the 
human breast milk cells are obtained in cells culture 
experiments, using different in vitro conditions 
and probably, for this reason, these informations 
are in some cases in contrast and difficult to 
analyze. Therefore, as previously suggested, the 
standardization of sampling protocols for studies 
of breast milk cells is very important and still more 
data need to be determined in the fresh milk. 
 
Preliminary personal data
In this contest, our preliminary results in 
fresh human breast milk cells suggest that one 
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of the best marker for the identification of MSCs in 
human milk is the surface marker CD44. In order to 
use standard conditions for immunohistochemical 
process, in these experiments fresh human milk 
was centrifuged and then the pellet was stored 
in commercial Cytological ThinPrep® solution 
(Hologic® Inc.). Microscope cytological slides 
were obtained using the automatic ThinPrep® 
processor (Hologic® Inc.) and these slides 
were used for standard immunohistochemical 
reactions performed with an automated stainer 
(Dako).
Fig. 1 shows that only few cells are CD44 posi- 
tive, suggesting that this marker may discriminate, 
among the total cells present in the milk, some 
putative MSCs.
These are single cells or, in some cases, are 
grouped as two or more cells together, which may 
be CD44 positive, or both positive and negative. 
In another experiment, using different fresh human 
milk samples, we obtained the variation of the 
CD44-positive cells during different gestational and 
lactation periods (Fig. 2). These preliminary results 
suggest that, in our experimental conditions, the 
Figure 1. Putative mesenchimal stem cells of human breast milk positive for the CD44 immunohistochemical reaction. A. 
Total cells founded in fresh human breast milk, only few cells are CD44 positive. B. A single cell half positive for CD44. C. 
and D. A group of fresh human breast milk cells with different expression of CD44 marker.
A.
B.
C.
D.
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percentage of CD44-positive cells might decrease 
during lactation. 
Although stem cells are believed to divide 
infinitely by self-renewal division, it is not clear 
if they have infinite replicative potential. Several 
reports suggest that also the mechanism of 
programmed cell death in this type of cells could 
be different as compared to that of normal somatic 
cells [29].
Evidence for extrinsic aging and various aging 
markers relating to morphology, proliferation, 
signaling, senescence markers, telomeres and 
telomerase, and other indicators start to be 
investigated also in stem cells [30].
We try to investigate if, in fresh human breast 
milk, a cell cycle marker like Ki67 (MIB-1) may 
give some information about the state of the cells 
present in this biological fluid.
As it is shown in Fig. 3, a few percentage of 
cells resulted positive for this marker and, among 
these, one was characterized by the presence of 
several fragment of the nucleus, all positive for 
the immunoreactions of the marker Ki67 (Fig. 
3C). Nucleus fragmentation is a typical apoptotic 
event; therefore, this cell could be an hypothetical 
stem cell that, after proliferation, was blocked in a 
phase of the cell cycle and then was eliminated by 
apoptosis. This possibility is in part supported by 
some evidences previously published [29, 31].
 
Conclusions
We can summarize the importance of stem cells 
with the final prospective written by the 2007 Nobel 
Prize winner in Physiology and Medicine Martin 
J. Evans: “With the advent of human embryonic 
stem cells and the possibilities of using them as 
a renewable source of tissue-specific precursors 
for tissue transplant therapies and regenerative 
medicine, the importance of understanding and 
controlling embryonic stem cell determination 
and differentiation in vitro has been highlighted. 
It is clear that the utility of isolation, maintenance 
and use of pluripotential stem cells has a long and 
important future” [32].
Finally, coming back to breast milk stem 
cells, our preliminary data indicate these as a 
fascinating field of research in which, thanks to 
the cooperation of perinatologists, biologists and 
molecular pathologists, we might obtain new data 
on the complex relationship between the lactating 
mother and the newborn after birth.
Figure 2. Graphic representation of the percentage of CD44-positive fresh human breast milk cells during different weeks 
of gestation (W) and days of lactation (D).
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